A Pancreatitis-Inspired Trypsinogen Nanoplatform Reprograms Tumor-Associated Macrophages via NF-κB for Pancreatic Cancer Immunotherapy
This journal article was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.
This journal article was triaged for T6 - Novel Therapeutics (immunotherapy/CAR-T) based on abstract review. It appears standard priority because it addresses a direct clinical or diagnostic question with limited evidence maturity.
What the study was
- Study design
- Journal article
- Maturity
- Exploratory
- Journal
- Advanced science (Weinheim, Baden-Wurttemberg, Germany)
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.